Biosimilars

An Amgen sign is seen at the company's office in South San Francisco
Health

Amgen Is Taking On a $3 Billion Cancer Drug. But Will It Cut Costs for Patients?

By
September 15, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Rise Amid Stronger Job Gains Boost Optimism On Economy
Health

This Biotech’s Stock Plunged 24% After the FDA Rejected Its Amgen Drug Copycat

By
June 12, 2017
CA: Companies In California
Health

The World’s Best-Selling Drug Just Lost a Key Patent Battle

By
May 18, 2017
FDA Approves New Drug That Could Take a Slice Out of Johnson & Johnson’s Best Seller
Health

FDA Approves New Drug That Could Take a Slice Out of Johnson & Johnson’s Best Seller

By
April 24, 2017
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Health

Why These Copycat Drugs Aren’t Slashing Best-Sellers’ Prices

By
October 18, 2016
The Davos World Economic Forum 2015
Health

Novartis Just Got Some Great News in Its Battle for Amgen’s Market Share

By
August 31, 2016
The Davos World Economic Forum 2015
Health

Amgen Finally Scores a Win in Its Big Copycat Drug Battle With Novartis

By
July 19, 2016
Close up of surgical tools and money
Health

Two of the World’s Best-Selling Drugs Are Headed for a Lot More Competition

By
July 15, 2016
Why a Bipartisan Bill Is Pitting the Biopharma Industry Against Itself
Health

Why a Bipartisan Bill Is Pitting the Biopharma Industry Against Itself

By
June 28, 2016
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
Health

How Mylan Is Taking On One of the World’s Top Breast Cancer Drugs

By
June 5, 2016
Samsung Holds Shareholders Meeting
Tech

Samsung Has a Best-Selling American Drug in Its Crosshairs

By
May 24, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
Health

Samsung’s Drug Group Is Taking AbbVie to Court in Biotech Copycat Push

By
April 4, 2016
The U.S. and Europe Could Save $110 Billion With Copycat Biotech Drugs
Health

The U.S. and Europe Could Save $110 Billion With Copycat Biotech Drugs

By
March 29, 2016
Exclusive Look At Pharmaceuticals Manufacturing Inside Lupin Ltd. Facility, India's Third-Largest Drugmaker
Finance

Indian Companies Want to Sell U.S. Customers More Drugs

By
February 25, 2016
Biosimilars Are Coming After Big Pharma’s Bottom Line
Health

Biosimilars Are Coming After Big Pharma’s Bottom Line

By
January 12, 2016

Most Popular